164 related articles for article (PubMed ID: 14698784)
21. 99mTc-Tetraethylenepentamine-Folate--a new 99mTc-based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation.
Panwar P; Shrivastava V; Tandon V; Mishra P; Chuttani K; Sharma RK; Chandra R; Mishra AK
Cancer Biol Ther; 2004 Oct; 3(10):995-1001. PubMed ID: 15467429
[TBL] [Abstract][Full Text] [Related]
22. [Folate receptor and its application in the selective receptor-mediated targeting therapy of tumor cells--review].
Gao XN; Tang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):911-4. PubMed ID: 16277870
[TBL] [Abstract][Full Text] [Related]
23. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.
Müller C; Schibli R
J Nucl Med; 2011 Jan; 52(1):1-4. PubMed ID: 21149477
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS
Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
Dixit V; Van den Bossche J; Sherman DM; Thompson DH; Andres RP
Bioconjug Chem; 2006; 17(3):603-9. PubMed ID: 16704197
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of receptor-based tumor imaging agent: (99m)Tc-folate-glucaric acid.
Onursal M; Lambrecht FY; Ozgur A
Int J Pharm; 2011 Sep; 416(1):288-92. PubMed ID: 21782912
[TBL] [Abstract][Full Text] [Related]
28. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
Henriksen G; Bruland OS; Larsen RH
Anticancer Res; 2005; 25(1A):9-15. PubMed ID: 15816513
[TBL] [Abstract][Full Text] [Related]
29. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
30. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
31. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
Ayala-López W; Xia W; Varghese B; Low PS
J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
[TBL] [Abstract][Full Text] [Related]
32. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe.
Kennedy MD; Jallad KN; Thompson DH; Ben-Amotz D; Low PS
J Biomed Opt; 2003 Oct; 8(4):636-41. PubMed ID: 14563201
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
[TBL] [Abstract][Full Text] [Related]
34. Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells.
Santra S; Liesenfeld B; Dutta D; Chatel D; Batich CD; Tan W; Moudgil BM; Mericle RA
J Nanosci Nanotechnol; 2005 Jun; 5(6):899-904. PubMed ID: 16060150
[TBL] [Abstract][Full Text] [Related]
35. [Folate receptor-mediated antitumor drugs].
Zhao J; Cao SL; Zheng XL; Zhao B
Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
[TBL] [Abstract][Full Text] [Related]
36. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans.
Lee D; Lockey R; Mohapatra S
J Nanosci Nanotechnol; 2006; 6(9-10):2860-6. PubMed ID: 17048492
[TBL] [Abstract][Full Text] [Related]
37. Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.
Theti DS; Bavetsias V; Skelton LA; Titley J; Gibbs D; Jansen G; Jackman AL
Cancer Res; 2003 Jul; 63(13):3612-8. PubMed ID: 12839949
[TBL] [Abstract][Full Text] [Related]
38. From bench to bedside.
Eckelman WC; Vera DR
Nucl Med Biol; 2003 Nov; 30(8):793-4. PubMed ID: 14698781
[No Abstract] [Full Text] [Related]
39. Folate-targeted therapeutic and imaging agents for cancer.
Low PS; Kularatne SA
Curr Opin Chem Biol; 2009 Jun; 13(3):256-62. PubMed ID: 19419901
[TBL] [Abstract][Full Text] [Related]
40. Folic acid-conjugated nanostructured materials designed for cancer cell targeting.
Pan D; Turner JL; Wooley KL
Chem Commun (Camb); 2003 Oct; (19):2400-1. PubMed ID: 14587701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
